Monitor for the compliance plan submission by October 20, 2026 and any subsequent Nasdaq acceptance. The key catalyst is whether the company can file the delinquent 10-Q before February 16, 2027. Failure to regain compliance would likely trigger delisting, severely impairing liquidity for this micro-cap stock.
Price Chart
Executive Summary
BioRestorative Therapies received a Nasdaq delinquency notice for failing to timely file its Q2 2026 Form 10-Q, violating Listing Rule 5250(c)(1). The company has until October 20, 2026 to submit a compliance plan; if accepted, it may have until February 16, 2027 to file. Failure to regain compliance risks delisting from the Nasdaq Capital Market, which would severely impact liquidity for this $5M market cap stock.
Key Facts
- Received Nasdaq delinquency notice on August 21, 2026 for late filing of Q2 2026 Form 10-Q
- Must submit a plan to regain compliance by October 20, 2026
- If plan accepted, Nasdaq may grant exception until February 16, 2027 to file
- Non-compliance with Nasdaq Listing Rule 5250(c)(1) — timely filing of periodic reports
- Stock continues trading on Nasdaq Capital Market under BRTX with no immediate delisting effect
- Market cap is approximately $5M, making compliance resources potentially constrained
Financial Impact
No financial figures reported in the filing. Risk of delisting could eliminate public market liquidity for a $5M market cap stock.
Risk Factors
- Delisting from Nasdaq if Form 10-Q is not filed by February 16, 2027
- Limited internal resources to complete financial statements for a $5M market cap company
- Potential Nasdaq rejection of compliance plan leading to accelerated delisting timeline
- Loss of institutional ownership and liquidity upon delisting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (BRTX) — Batch item 1 | 0001213900-26-093566 |
| Document: 0001213900-26-093566-index.html | 0001213900-26-093566 |
| Document: 0001213900-26-093566.txt | 0001213900-26-093566 |
| 8-K Filing (BRTX) — Batch item 4 | 0001213900-26-093566 |
| Document: 0001213900-26-093566-index.html | 0001213900-26-093566 |
| Document: 0001213900-26-093566.txt | 0001213900-26-093566 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 16d ago | 8-K | $1.75 | awaiting T+20 | — | $1.56 (−10.86%) |
Sep 11, 2026 6w ago | 8-K | $2.67 $1.91 | ▲ +28.46% | ▲ +30.33% | $1.56 (+41.57%) |
Sep 2, 2026 7w ago | Press Release | $0.1437 $2.14 | ▲ +1389.21% | ▲ +1389.67% | $1.56 (+985.59%) |
Aug 25, 2026 8w ago | 8-K | $0.2169 $2.51 | ▼ −1057.22% | ▼ −1057.07% | $1.56 (−619.23%) |
Jun 12, 2026 19w ago | 8-K | $0.3910 $0.3400 | ▲ +13.04% | ▲ +13.04% | $1.56 (−298.98%) |
May 29, 2026 21w ago | 8-K | $0.4064 $0.3760 | ▲ +7.48% | ▲ +6.18% | $1.56 (−283.86%) |
May 1, 2026 25w ago | 8-K | $0.2420 $0.4064 | ▲ +67.93% | ▲ +62.29% | $1.56 (+544.63%) |
Apr 7, 2026 28w ago | Press Release | $0.2507 $0.2420 | ▼ −3.47% | ▼ −13.25% | $1.56 (+522.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers